PCP
ACAD icon

Proficio Capital Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Proficio Capital Partners’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-253
Closed -$7K – 134
2019
Q2 		$7K Hold
253
– – ﹤0.01% 1060
2019
Q1 		$7K Buy
253
+203
+406% +$4.74K ﹤0.01% 984
2018
Q4 		$1K Buy
+50
New +$971 ﹤0.01% 1075
2018
Q3 		– Sell
-16
Closed – – 1243
2018
Q2 		$0 Sell
16
-257
-94% -$4.58K ﹤0.01% 1274
2018
Q1 		$6K Buy
273
+63
+30% +$1.74K ﹤0.01% 950
2017
Q4 		$6K Buy
210
+172
+453% +$5.5K ﹤0.01% 923
2017
Q3 		$1K Hold
38
– – ﹤0.01% 1136
2017
Q2 		$1K Hold
38
– – ﹤0.01% 1135
2017
Q1 		$1K Buy
38
+16
+73% +$565 ﹤0.01% 1185
2016
Q4 		$1K Buy
+22
New +$582 ﹤0.01% 977

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return